131 related articles for article (PubMed ID: 7797193)
1. Current awareness in hematological oncology.
Hematol Oncol; 1995; 13(2):109-18. PubMed ID: 7797193
[No Abstract] [Full Text] [Related]
2. Current awareness in hematological oncology.
Hematol Oncol; 1995; 13(1):49-58. PubMed ID: 7750928
[No Abstract] [Full Text] [Related]
3. Recent publications in hematological oncology.
Hematol Oncol; 2007 Sep; 25(3):148-55. PubMed ID: 17957827
[No Abstract] [Full Text] [Related]
4. General principles of treatment.
Schouten HC
Ann Oncol; 2007 Jan; 18 Suppl 1():i29-i32. PubMed ID: 17311818
[No Abstract] [Full Text] [Related]
5. Management of elderly patients with hematological neoplasms.
Mora O; Zucca E
Ann Oncol; 2007 Jan; 18 Suppl 1():i49-i53. PubMed ID: 17311823
[No Abstract] [Full Text] [Related]
6. Response evaluation and long-term follow-up.
Schouten HC
Ann Oncol; 2007 Jan; 18 Suppl 1():i33-i36. PubMed ID: 17311820
[No Abstract] [Full Text] [Related]
7. [Cytogenetic studies in the hematologic neoplasias].
Solé F; Woessner S
Sangre (Barc); 1995 Dec; 40(6):521. PubMed ID: 8850241
[No Abstract] [Full Text] [Related]
8. 2nd International Congress on Leukemia, Lymphoma and Myeloma.
Arat M; Ozsan GH; Yenerel MN; Cetin M; Ozcan M
Expert Rev Hematol; 2009 Oct; 2(5):509-12. PubMed ID: 21083016
[TBL] [Abstract][Full Text] [Related]
9. Clinical and microbiological impact of long-term discontinuation of fluoroquinolone prophylaxis in haematological patients with prolonged profound neutropenia.
Verlinden A; Schroyens WA; Gadisseur AP
Eur J Haematol; 2021 Sep; 107(3):377-379. PubMed ID: 34018235
[No Abstract] [Full Text] [Related]
10. [Interferons: Clinical applications in hematology].
Ben Rhomdhane N; Ben Ahmed M; Zitouni M; Mtimet B
Tunis Med; 1998 Dec; 76(12):427-36. PubMed ID: 10093482
[No Abstract] [Full Text] [Related]
11. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1990; 11():321-42. PubMed ID: 2223398
[No Abstract] [Full Text] [Related]
12. Leukemias and plasma cell myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1992; 13():327-48. PubMed ID: 1389914
[No Abstract] [Full Text] [Related]
13. [Elderly cases of hematological malignancies with second malignancies].
Ueno H; Hino K; Ishiyama T; Akimoto Y; Tomoyasu S; Tsuruoka N
Nihon Ronen Igakkai Zasshi; 1993 Sep; 30(9):802-6. PubMed ID: 8230794
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic cell transplantation for concurrent multiple myeloma and myelodysplastic syndrome.
Nishihori T; Komrokji R; Shain K; Anasetti C
Bone Marrow Transplant; 2015 Feb; 50(2):296-7. PubMed ID: 25330222
[No Abstract] [Full Text] [Related]
15. Stromal abnormalities in neoplastic bone marrow diseases.
Dührsen U; Hossfeld DK
Ann Hematol; 1996 Aug; 73(2):53-70. PubMed ID: 8774614
[TBL] [Abstract][Full Text] [Related]
16. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1991; 12():327-46. PubMed ID: 1931449
[No Abstract] [Full Text] [Related]
17. International Meeting on the Therapy of Hematological Malignancies in the Elderly. Proceedings. Turin, 15-16 April 1993.
Hematol Oncol; 1993; 11 Suppl 1():1-84. PubMed ID: 8486335
[No Abstract] [Full Text] [Related]
18. Hematology-oncology. Hematology-Oncology Workgroup, Legislative Task Force on Cancer in Texas.
Gardner FH; Alperin JB; Belli JA; Farley PC; Frenkel EP; Redman JR; Roodman GD; Sears DA; Trowbridge AA
Tex Med; 1987 Sep; 83(9 Pt 2):59-71. PubMed ID: 3672407
[No Abstract] [Full Text] [Related]
19. Current awareness in hematological oncology.
Hematol Oncol; 1994; 12(4):195-204. PubMed ID: 8001906
[No Abstract] [Full Text] [Related]
20. [Clinical use of alpha-interferon in onco-hematology: conclusions and prospects].
Bernasconi C
Haematologica; 1990; 75 Suppl 4():82-4. PubMed ID: 2074058
[No Abstract] [Full Text] [Related]
[Next] [New Search]
